Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II study. (Q43573420)
Jump to navigation
Jump to search
scientific article published in February 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II study. |
scientific article published in February 2001 |
Statements
Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II study (English)
M Ermani
P AmistÃ
F Berti
R Scienza
A Rotilio
G Pinna
1 February 2001